Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The negative feedback loop FAM129A/CXCL14 aggravates the progression of esophageal cancer. | Eur Rev Med Pharmacol Sci | 2022 | 35776020 | PubTator, text mining | PubMed |
| Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer. | Front Pharmacol | 2022 | 35770088 | PubTator, text mining | PubMed |
| Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer. | Front Oncol | 2022 | 35769715 | PubTator, text mining | PubMed |
| Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer. | Front Immunol | 2022 | 35769483 | PubTator, text mining | PubMed |
| Single-cell Transcriptomics Reveals Dynamic Role of Smooth Muscle Cells and Enrichment of Immune Cell Subsets in Human Abdominal Aortic Aneurysms. | Ann Surg | 2022 | 35762613 | PubTator, text mining | PubMed |
| Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma. | Front Pharmacol | 2022 | 35754466 | PubTator, text mining | PubMed |
| Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression. | J Immunother Cancer | 2022 | 35750419 | PubTator, text mining | PubMed |
| Identification of pathways and key genes in male late-stage carotid atherosclerosis using bioinformatics analysis. | Exp Ther Med | 2022 | 35747144 | PubTator, text mining | PubMed |
| Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation. | Int J Mol Sci | 2022 | 35743318 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analysis of the Mouse Pancreas: Characteristic Features of Pancreatic Ductal Cells in Chronic Pancreatitis. | Genes (Basel) | 2022 | 35741777 | PubTator, text mining | PubMed |
| Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells. | Biomolecules | 2022 | 35740975 | PubTator, text mining | PubMed |
| The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas. | Cancers (Basel) | 2022 | 35740551 | PubTator, text mining | PubMed |
| The sculpting of somatic mutational landscapes by evolutionary forces and their impacts on aging-related disease. | Mol Oncol | 2022 | 35726685 | PubTator, text mining | PubMed |
| A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer. | Sci Rep | 2022 | 35725915 | PubTator, text mining | PubMed |
| Cortical VIP+ Interneurons in the Upper and Deeper Layers Are Transcriptionally Distinct. | J Mol Neurosci | 2022 | 35708842 | PubTator, text mining | PubMed |
| Circadian protection against bacterial skin infection by epidermal CXCL14-mediated innate immunity. | Proc Natl Acad Sci U S A | 2022 | 35704759 | PubTator, text mining | PubMed |
| Role of chemokine systems in cancer and inflammatory diseases. | MedComm (2020) | 2022 | 35702353 | PubTator, text mining | PubMed |
| Human-host transcriptomic analysis reveals unique early innate immune responses in different sub-phenotypes of COVID-19. | Clin Transl Med | 2022 | 35696527 | PubTator, text mining | PubMed |
| Characterization of the Prognostic Values of CXCL Family in Epstein-Barr Virus Associated Gastric Cancer. | Oxid Med Cell Longev | 2022 | 35693706 | PubTator, text mining | PubMed |
| A novel seven-gene risk profile in BALF to identify high-risk patients with idiopathic pulmonary fibrosis. | J Thorac Dis | 2022 | 35693599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=40